ADVERTISEMENTs
US Academy of Medicine names Indian-origin researchers as emerging leaders
Arnab K. Ghosh and Raman Bahal have been chosen for the Emerging Leaders in Health and Medicine (ELHM) program.
-
Malvika Choudhary - Fri, 30, May 2025
- 14:13 EDT
- 9
Arnab K. Ghosh and Raman Bahal / Cornell University/ University of Connecticut
Two Indian-origin researchers were named among the ten emerging leaders selected by the U.S. National Academy of Medicine for its 2025 program.
Arnab K. Ghosh and Raman Bahal were chosen for the Emerging Leaders in Health and Medicine (ELHM) program, a three-year initiative that brings together early- to mid-career professionals working to improve health and medicine across disciplines.
The ELHM program identifies experts from diverse health-related fields and provides them a platform to collaborate with the NAM on pressing health challenges. The 2025 cohort includes professionals from pediatrics, psychiatry, infectious diseases, biomedical engineering, and pharmaceutical sciences.
Also Read: Two Indian-origin scientists named to “Talented 12” by C&EN
Arnab Ghosh serves as an assistant professor of medicine at Weill Cornell Medicine, Cornell University. His research focuses on the intersection of climate change and public health, addressing issues such as extreme heat exposure, cardiovascular outcomes, and healthcare disparities.
Ghosh has led multiple federally funded projects examining public health emergencies and climate-related health risks. In 2024, he was named a Climate and Health Scholar by the National Institutes of Health (NIH), working with the National Institute on Aging to reduce health threats from climate change and build resilience in vulnerable communities. He completed his MBBS from Medical College Kolkata before pursuing further studies in the United States.
Raman Bahal is an associate professor in the department of pharmaceutical sciences at the University of Connecticut. His research centers on gene-targeting therapies and the development of novel delivery strategies for nucleic acid analogues, aiming to treat genetic diseases and target cancer-related microRNAs.
Bahal holds a doctorate in chemistry from Carnegie Mellon University and completed postdoctoral training at Yale University. He has been recognized with several awards, including the NIPTE Rising Star Scholar award in 2021. He completed his undergraduate degree in pharmacy at Panjab University, Chandigarh, before moving to the U.S. for graduate studies.
The selected scholars will serve a three-year term, during which they will participate in activities at the National Academies of Sciences, Engineering, and Medicine. These include meetings in Washington, D.C., publishing NAM Perspectives, and helping plan the annual Emerging Leaders Forum. The next forum is scheduled for April 2026.
Established in 1970 as the Institute of Medicine, the NAM is part of the National Academies of Sciences, Engineering, and Medicine. It serves as an independent adviser on issues related to health, science, and policy, both in the U.S. and internationally.
Related
.JPG)
.jpg)
.jpg)
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
E Paper
ADVERTISEMENT
.jpg)
Video
Comments
Start the conversation
Become a member of New India Abroad to start commenting.
Sign Up Now
Already have an account? Login